Mya S. Walker, PhD is a scientist at iNFixion Bioscience. She received her BS in Biological Sciences at California State University, Long Beach, and completed research internships at the Ohio State University and Cedars-Sinai Medical Center. She earned her PhD at the Irell & Manella Graduate School of Biological Sciences at City of Hope, where she studied the role of metabolic adducts on prostate cancer disparities affecting African American men. She brings to iNFxion a wide set of technical skills gained from her training in molecular biology, genetics, and population sciences. Since joining the lab team at iNFixion, Dr. Walker has led the development of our antisense oligonucleotide (ASO) program.